LEVETIRACETAM
| Brand name | SPRITAM |
|---|---|
| Active ingredient | LEVETIRACETAM |
| Strength | 250MG |
| Dosage form | TABLET, FOR SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9339489 | March 2034 | product |
| 9669009 | March 2034 | use U-1850 |
| 11160786 | March 2034 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.